E
Nuvectis Pharma, Inc. NVCT
$9.44 -$0.05-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -19.00M -19.37M -21.10M -22.38M -22.26M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 4.86M 4.94M 4.91M 4.60M 4.71M
Change in Net Operating Assets 1.90M 805.00K 1.72M 2.25M 1.60M
Cash from Operations -12.25M -13.63M -14.47M -15.54M -15.95M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 12.04M 8.98M 8.62M 20.63M 16.48M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -382.00K -242.00K -629.00K -1.10M -1.39M
Cash from Financing 11.65M 8.74M 7.99M 19.53M 15.09M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -593.00K -4.89M -6.48M 4.00M -867.00K
Weiss Ratings